The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Kwon JS. Improving survival after endometrial cancer: the big picture. J Gynecol Oncol 2015; 26:227-31; PMID:26197859; http://dx.doi.org/10.3802/jgo.2015.26.3.227
   PubMed Web of Science ®Google Scholar
• Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol 2013; 129:258-64; PMID:23266352; http://dx.doi.org/10.1016/j.ygyno.2012.12.016
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609-15; PMID:21720365; http://dx.doi.org/10.1038/nature10166
   PubMed Web of Science ®Google Scholar
• Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstet Gynecol 2015; 126:491-7; PMID:26244529; http://dx.doi.org/10.1097/AOG.0000000000000981
   PubMed Web of Science ®Google Scholar
• Cui Y, Wang Y, Li H, Li Q, Yu Y, Xu X, Xu B, Liu T. Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways. Oncotarget 2016; 7(23):34356-70; PMID:27102302
   PubMed Web of Science ®Google Scholar
• Miller G, Matthews SP, Reinheckel T, Fleming S, Watts C. Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J 2011; 25:1606-17; PMID:21292981; http://dx.doi.org/10.1096/fj.10-172312
   PubMed Web of Science ®Google Scholar
• Andrade V, Guerra M, Jardim C, Melo F, Silva W, Ortega JM, Robert M, Nathanson MH, Leite F. Nucleoplasmic calcium regulates cell proliferation through legumain. J Hepatol 2011; 55:626-35; PMID:21237226; http://dx.doi.org/10.1016/j.jhep.2010.12.022
   PubMed Web of Science ®Google Scholar
• Guo P, Zhu Z, Sun Z, Wang Z, Zheng X, Xu H. Expression of legumain correlates with prognosis and metastasis in gastric carcinoma. PloS One 2013; 8:e73090; PMID:24023813; http://dx.doi.org/10.1371/journal.pone.0073090
   PubMedGoogle Scholar
• Li N, Liu Q, Su Q, Wei C, Lan B, Wang J, Bao G, Yan F, Yu Y, Peng B, et al. Effects of legumain as a potential prognostic factor on gastric cancers. Med Oncol 2013; 30:621; PMID:23740003; http://dx.doi.org/10.1007/s12032-013-0621-9
   PubMed Web of Science ®Google Scholar
• Lin Y, Qiu Y, Xu C, Liu Q, Peng B, Kaufmann GF, Chen X, Lan B, Wei C, Lu D, et al. Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis. J Natl Cancer Inst 2014; 106:dju012; PMID:24610907; http://dx.doi.org/10.1093/jnci/dju012
   PubMedGoogle Scholar
• Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K. High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting. Euro J Cancer 2015; 51:9-17; PMID:25466510; http://dx.doi.org/10.1016/j.ejca.2014.10.020
   PubMed Web of Science ®Google Scholar
• Lin Y, Wei C, Liu Y, Qiu Y, Liu C, Guo F. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer Sci 2013; 104:1217-25; PMID:23691974; http://dx.doi.org/10.1111/cas.12202
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 2015; 527:100-4; PMID:26479035; http://dx.doi.org/10.1038/nature15376
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi.org/10.1002/ijc.25516
   PubMed Web of Science ®Google Scholar
• Zhang W, Barger CJ, Eng KH, Klinkebiel D, Link PA, Omilian A, Bshara W, Odunsi K, Karpf AR. PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget 2016; 7(29):45352-69; PMID:27322684; http://dx.doi.org/10.18632/oncotarget.9977
   PubMed Web of Science ®Google Scholar
• Foley OW, Rauh-Hain JA, del Carmen MG. Recurrent epithelial ovarian cancer: an update on treatment. Oncology 2013; 27:288-94, 298; PMID:23781692
   PubMed Web of Science ®Google Scholar
• Ribeiro JR, Schorl C, Yano N, Romano N, Kim KK, Singh RK, Moore RG. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. J Ovarian Res 2016; 9:28; PMID:27184254; http://dx.doi.org/10.1186/s13048-016-0240-0
   PubMed Web of Science ®Google Scholar
• Hou MM, Wang Z, Janku F, Piha-Paul S, Naing A, Hong D, Westin S, Coleman RL, Sood AK, Tsimberidou AM, et al. Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. Oncotarget 2016; 7(23):35132-43; PMID:27147567; http://dx.doi.org/10.18632/oncotarget.9048
   PubMed Web of Science ®Google Scholar
• Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C, Barrett AJ. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 1997; 272:8090-8; PMID:9065484; http://dx.doi.org/10.1074/jbc.272.12.8090
   PubMed Web of Science ®Google Scholar
• Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K, et al. Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett 2007; 581:1417-24; PMID:17350006; http://dx.doi.org/10.1016/j.febslet.2007.02.064
   PubMed Web of Science ®Google Scholar
• Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Duménil AM, Amigorena S, Cabanie L, Manoury B. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 2009; 31:737-48; PMID:19879164; http://dx.doi.org/10.1016/j.immuni.2009.09.013
   PubMed Web of Science ®Google Scholar
• Havugimana PC, Hart GT, Nepusz T, Yang H, Turinsky AL, Li Z, Wang PI, Boutz DR, Fong V, Phanse S, et al. A census of human soluble protein complexes. Cell 2012; 150:1068-81; PMID:22939629; http://dx.doi.org/10.1016/j.cell.2012.08.011
   PubMed Web of Science ®Google Scholar